The Catalyst Group
Catalysts and Specialty Chemicals
Fine Chemicals and Pharmaceuticals
Polymers and Elastomers
Combinatorial Chemistry
Refining and Petrochemicals
Chemicals
Strategic Technology Consultings
Multi-Client Studies
Membership Programs
Conferences
Key People
Publications
News/Press Releases
Contact Us
BioCat 2002

DAY TWO AGENDA

Friday, April 26, 2002

8:00am-9:00am Welcome Coffee & "Visit the Exhibits"
SESSION IV:
Advances in BioPolymers
Chairman: Mr. Clyde Payn, The Catalyst Group
9:00-9:30am Cargill Dow Presentation on PLA Developments
Dr. Chris Ryans, Cargill Dow LLD
9:30-10:00am Biological Production of 1,3 Propanediol
Dr. Scott E. Nichols, DuPont
10:00-10:30am Metabolix's PHA Development Status
Dr. James Barber, Metabolix
10:30-11:00am Morning Break & "Visit the Exhibits"
SESSION V:
Advances in Biochemicals
Chairman: Dr. Keith Powell, Maxygen
11:00-11:30am Enhanced Cellulase Systems for Biomass Conversion
Mr. Colin Mitchinson, Genencor International, Inc.
11:30-12:00pm Iogen's Biomass Conversion Updates
Mr. Jeff Passmore, Iogen Corporation
12:00-12:30pm Presentation TBA
12:30-1:30pm Lunch on Own
1:30-2:00pm Production of Ethanol from Cellulose Sugars
Dr. Stan Bower, NREL
2:00-2:30pm Large Scale Production of Doramectin using Enzyme Engineering, Dr. Hamish McArthur, Pfizer
SESSION VI:
New Methods to Speed Development
Chairman: Dr. Ian Fotheringham, Thermogen
2:30-3:00pm Technologies for Rapid Bioprocess Development,
Dr. Francisco Mons-Varas, MediChem/Thermogen
3:00-3:30pm Afternoon Break & "Visit the Exhibits"
3:30-4:00pm The Biocatalytic Process Modeling to Speed Development,
Dr. John Woodley, University College London
4:00-4:30pm The Development of an Efficient Biotransformation System for P-450 cam in Escherichia coli,
Dr. Robert Speight, University of Edinburgh
4:30-5:00pm SPECIAL FEATURE: The Advanced Technology Program - Enabling Biocatalysis-Based Industries,
Mr. Robert Bloksberg-Fireovid, N.I.S.T.
5:00pm Closing Remarks
PLEASE NOTE: This program is accurate as of press time; substitutions may be required in the case of illness or other unforeseen circumstances. The Catalyst Group reserves the right to make these changes.

Back to BioCat2002 - Europe


Copyright ©2002 by The Catalyst Group, Inc., Catalyst Group Resources, Inc., and Catalyst Consultants Publishing. All rights reserved.